Metagenomi, Inc. Common Stock (MGX) EBITDA Yield: History & Chart

Metagenomi, Inc. Common Stock(MGX)

Biotechnology · Emeryville, CA

$1.03-0.01 (-0.96%)

Delayed quote: Oct 6, 2026, 4:00 PM EDT

About Metagenomi, Inc. Common Stock

Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.

Emeryville, CA

113 employees

www.metagenomi.co

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Jian Irish

View full financials

NAME	MARKET CAP	EBITDA YIELD	TTM	3Y	5Y
Metagenomi, Inc. Common Stock (MGX)	$38.78M	N/A	N/A	N/A	N/A
Harvard Bioscience, Inc. (HBIO)vs ›	$38.61M	9.49%	10.40%	3.98%	3.32%
Incannex Healthcare Limited (IXHL)vs ›	$37.93M	N/A	N/A	N/A	N/A
Veru Inc. (VERU)vs ›	$39.64M	N/A	0.98%	0.98%	0.99%
EUDA Health Holdings Limited (EUDA)vs ›	$36.21M	N/A	0.01%	0.01%	0.01%
Elicio Therapeutics, Inc. (ELTX)vs ›	$35.84M	N/A	N/A	N/A	N/A
Edesa Biotech, Inc. (EDSA)vs ›	$35.84M	N/A	N/A	N/A	N/A
DocGo Inc. (DCGO)vs ›	$35.76M	N/A	15.63%	9.19%	7.93%
Precipio, Inc. (PRPO)vs ›	$41.83M	N/A	0.46%	0.46%	0.46%
BioStem Technologies, Inc. (BSEM)vs ›	$41.95M	N/A	14.45%	11.70%	11.70%

NAME

MARKET CAP

EBITDA YIELD

TTM

Metagenomi, Inc. Common Stock (MGX)

$38.78M

N/A

Harvard Bioscience, Inc. (HBIO)vs ›

$38.61M

9.49%

10.40%

3.98%

3.32%

Incannex Healthcare Limited (IXHL)vs ›

$37.93M

N/A

Veru Inc. (VERU)vs ›

$39.64M

N/A

0.98%

0.99%

EUDA Health Holdings Limited (EUDA)vs ›

$36.21M

N/A

0.01%

Elicio Therapeutics, Inc. (ELTX)vs ›

$35.84M

N/A

Edesa Biotech, Inc. (EDSA)vs ›

$35.84M

N/A

DocGo Inc. (DCGO)vs ›

$35.76M

N/A

15.63%

9.19%

7.93%

Precipio, Inc. (PRPO)vs ›

$41.83M

N/A

0.46%

BioStem Technologies, Inc. (BSEM)vs ›

$41.95M

N/A

14.45%

11.70%

EBITDA Yield Formula & Definition

EBITDA Yield = TTM EBITDA / Enterprise Value

EBITDA yield is the inverse of EV/EBITDA, expressing trailing pre-interest, pre-tax operating cash generation as a percentage of enterprise value. Comparable across leverage levels; higher is cheaper. Not meaningful for banks and insurers.

EBITDA Yield: N/A

MGX EBITDA Yield Metrics

MGX Competitors' EBITDA Yield

EBITDA Yield Formula & Definition

Related Metrics